Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eloxx Pharmaceuticals Inc (OTCQB:ELOX)

8.40
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
3.10
Today|||52-Week Range
8.80
+5.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$431.9M

Company Description

Eloxx Pharmaceuticals, Inc. operates as a clinical stage company. It develops biopharmaceuticals. The company was founded on December 19, 2017 and is headquartered in Waltham, MA.

Contact Information

Eloxx Pharmaceuticals, Inc.
950 Winter Street
Waltham Massachusetts 02451
P:(781) 577-5300
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Robert E. WardChairman & Chief Executive Officer
Dori PelledVice President-Operations
Gregory L. WeaverChief Financial & Accounting Officer
Pedro HuertasChief Medical Officer